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The reconstruction of head and neck defects is of ma-jor importance in the complex treatment of head and neck cancer patients, allowing not only for an aesthetic closure of large defects after ablative surgery but also more importantly for functional recovery of swallow-ing, mastication, and speech.1 The use of microvascular 
anastomosed free flaps has gained wide acceptance within 
the last decades, based on the variety of donor sites and 
as a consequence of multitude of tissue compositions, al-
lowing for a defect-specific approach of reconstruction.2–4
Currently used free flaps in the head and neck are 
fasciocutaneous, musculocutaneous, and bone flaps.2 
The most commonly used fasciocutaneous flap in Eu-
rope is the radial forearm free flap,5 followed by the 
anterolateral thigh flap, which belongs to the family of 
perforator flaps.3,6–8 Other soft-tissue flaps are the rectus 
and latissimus dorsi flaps.9,10 For bony reconstructions, 
a fibular flap,11 an iliac crest, or a scapula flap can be 
used.12–14 For facial reanimation surgery, a free gracilis 
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Background: Complications after head and neck free-flap reconstructions are 
detrimental and prolong hospital stay. In an effort to identify related variables in 
a tertiary regional head and neck unit, the microvascular reconstruction activity 
over the last 5 years was captured in a database along with patient-, provider-, and 
volume-outcome–related parameters.
Methods: Retrospective cohort study (level of evidence 3), a modified Clavien-Din-
do classification, was used to assess severe complications.
Results: A database of 217 patients was created with consecutively reconstructed pa-
tients from 2009 to 2014. In the univariate analysis of severe complications, we found 
significant associations (P < 0.05) between type of flap used, American Society of An-
esthesiologists classification, T-stage, microscope use, surgeon, flap frequency, and 
surgeon volume. Within a binomial logistic regression model, less frequently versus 
frequently performed flap (odds ratio [OR] = 3.2; confidence interval [CI] = 2.9–3.5; 
P = 0.000), high-volume versus low-volume surgeon (OR = 0.52; CI = −0.22 to 0.82; 
P = 0.007), and ASA classification (OR = 2.9; CI = 2.4–3.4; P = 0.033) were retained as 
independent predictors of severe complications. In a Cox-regression model, surgeon 
(P = 0.011), site of reconstruction (P = 0.000), T-stage (P = 0.001), and presence of 
severe complications (P = 0.015) correlated with a prolonged hospitalization.
Conclusions: In this study, we identified a correlation of patient-related factors 
with severe complications (ASA score) and prolonged hospital stay (T-stage, site). 
More importantly, we identified several provider- (surgeon) and volume-related 
(frequency with which a flap was performed and high-volume surgeon) factors as 
predictors of severe complications. Our data indicate that provider- and volume- 
related parameters play an important role in the outcome of microvascular free-flap 
procedures in the head and neck region. (Plast Reconstr Surg Glob Open 2016;4:e1013; 
doi: 10.1097/GOX.0000000000001013; Published online 27 October 2016.)
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flap is the primary choice.2 In case of a complete pharyn-
geal reconstruction, a jejunum free flap is an option.15
Predictors of complications of free-flap surgeries in 
head and neck cancer patients have recently been de-
lineated in a group of 185 patients and are found to be 
age, smoking status, American Society of Anesthesiolo-
gists classification, preoperative hemoglobin, and peri-
operative fluid management.16 A more recent study on 
304 patients reports only stage of disease and pharyngo-
esophageal reconstruction to be associated with severe 
complications. A convincing association with flap type 
and indication was not found, neither with preoperative 
radiation nor with chemoradiation therapy.17
There is accumulating evidence that head and neck 
cancer is better treated in larger centers, in particular aca-
demic centers, and there is an evolving body of evidence 
for a volume–outcome association in the care of head and 
neck cancer patients, with high-volume hospitals and high-
volume surgeons providing significantly better survival.18–22 
In that sense, patients surgically treated in high-volume 
head and neck cancer centers have a 44% lower odds of 
mortality from acute complications than their counterparts 
treated in low-volume centers. Positive margins in the resec-
tion of oral cavity cancer are also associated with hospital 
case volume.18,23
Although there is ample evidence that surgeon vol-
ume, for example, in case of oral cavity cancers recon-
structed with various pedicled and free flaps, impacts the 
survival of these head and neck cancer patients,24 data on 
how volume- and provider-related factors might influence 
complications and/or duration of hospitalization after 
microvascular tissue transfer procedures are lacking. An 
explanation for this lack of data is the fact that as of now, 
no or few databases exist that gather follow-up data on 
complications associated with free-flap procedures, and 
volume–outcome association studies are best performed 
based on population-based administrative databases that 
neither exist.
To understand parameters influencing the peri-
operative rate of severe complications and length of 
hospitalization, we constructed a database consisting 
of 217 consecutively performed free-flap procedures. 
Besides typical patient-related factors, we also analyzed 
factors related to the provider and to the volume of 
activity.
Toward the end of this study, we confirmed an asso-
ciation between severe complications and comorbidities 
measured via the ASA classification, but more interesting-
ly, we found a correlation between severe complications 
and the frequency with which a flap was performed and 
moreover the operative volume of the surgeon.
METHODS
From 2009 to 2014, 217 consecutive patients, of whom 
202 were treated for a primary malignancy of the head 
and neck and 15 patients for secondary reconstructions 
and various head and neck traumas, underwent recon-
struction with a free microvascular anastomosed flap. The 
reconstruction was performed by 6 microvascular head 
and neck surgeons. Data on the patients were retrospec-
tively collected from the electronic patient charts, and a 
database was generated (Table 1). Given that immediate 
postoperative variables (severe complications and length 
of hospitalization) were assessed as primary endpoints, 
no patient was lost to follow-up. The study was approved 
by the institutional review board. One surgeon worked in 
2 institutions, and this activity was included in the data-
base. Patient- (T-stage, overall stage, ASA score, sex, pri-
or radiation therapy, localization of the reconstruction, 
type of flap, and age) and provider-related (surgeon and 
microscope vs loupe use) variables and volume-sensitive 
variables (surgeon volume and flap frequency) were in-
cluded. Volume-sensitive variables were derived from sur-
geon activity and frequency of flaps performed within the 
observation period of 5 years (Fig.  1).
Table 1. Patient Characteristics
Characteristics Value,	n/%
Average age, y 60 ± 14.5
Sex  
  Male 156/72.0
  Female 61/28.0
ASA classification  
  1, 2 169/78.2
  3, 4 46/21.8
Reconstruction type  
  Cancer 202/93.1
  Noncancer 15/6.9
Type of flap  
  Radial forearm 149/68.7
  Fibular 35/16.1
  Anterolateral thigh 15/6.9
  Scapula 3/1.4
  Rectus abdominis 5/2.3
  Jejunum 1/0.5
  Gracilis 2/0.9
  Iliac crest 7/3.2
Microscope use  
  Yes 137/64.3
  No 80/35.7
Surgeon  
  AA 40/18.4
  BB 2/1
  CC 8/3.7
  DD 37/17.1
  EE 21/9.7
  FF 109/50.2
Site  
  Oropharynx 42/19.4




  Maxilla and others 51/23.5
  Mandible 10/4.6
T-stage  
  1, 2 82/42.9
  3, 4 109/57.1
N-stage  
  0, 1 113/59.2
  2+ 78/40.8
Stage  
  Early 39/20.4
  Advanced 152/79.6
Prior radiotherapy  
  Yes 38/17.6
  No 178/82.4
Values are provided in total (n) and as percentage (%). Flaps performed 
(within observation period) refer to frequently (>100) and less frequently 
(<100) used flaps; radiotherapy type has been not further defined.
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Every cancer patient was discussed in a multidisciplinary 
tumor board of the medical centers for treatment decision 
making. Staging was performed via a triple endoscopy with 
biopsy and imaging. Imaging modalities consisted of either 
computed tomography with contrast or magnetic resonance 
imaging. The stage of the disease was determined after the 
surgical resection of the tumor according to the TNM system 
of the International Union against Cancer (7th edition). The 
indication for adjuvant treatment was based on nodal status 
and margins. In case of positive permanent margins, the pa-
tient received adjuvant chemoradiation.
The surgical approach was dependent on the location 
of the disease and the reconstructive needs. For oral cav-
ity malignancies requiring a free-flap procedure, either 
a fasciocutaneous flap was used or a bone flap in case of 
mandible involvement. For oropharyngeal and laryngeal/
hypopharyngeal reconstruction, fasciocutaneous flaps were 
used. For maxillary reconstruction bone flaps, fasciocutane-
ous and musculocutaneous flaps were used. Microvascular 
anastomosis was performed either with an operation micro-
scope (Leica OH5, Leica Microsystems, Wetzlar, Germany; 
Zeiss S8, Carl Zeiss Meditec AG, Jena, Germany) or with 
magnifying loupes (3.5-fold). Arteries and veins were both 
sewn using either 8.0 or 9.0 Prolene sutures.
Surgical complications were rated using a modified Cla-
vien-Dindo (CD) grading system.25,26 The modified grading 
system adds 1 additional category distinguishing between 
patients requiring a surgical, endoscopic, or radiological 
intervention for hematoma evacuation without wound-healing 
complications, minor wound dehiscence, or vascular complication 
with complete functional salvage of the flap and those requiring 
intervention for fistulas, or complete or partial flap loss result-
Fig. 1. Volume-sensitive variables. a, Surgeons were grouped according to their activity in percent 
free flaps performed within the observation period and then assigned to the “high-volume” (FF), the 
“moderate-volume” (aa, DD), and the “low-volume” (BB, cc, ee) group of surgeons. B, Free flaps were 
grouped according to their frequency of use during the observation period and then assigned to the 
“frequent” (radial forearm), the “moderately frequent” (fibula, antero-lateral thigh), and “rare” (scapula, 
rectus, jejunum, gracilis, iliac crest) groups.
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ing in additional procedures (Table 2). A severe complication 
according to this novel classification is a complication re-
quiring a surgical, endoscopic, or radiological intervention 
for fistulas or complete or partial flap loss resulting in additional 
procedures (ie, fistula formation or flap losses/partial losses 
requiring additional major interventions, ie, additional 
[regional] flaps or repetitive wound dressings including 
vacuum-assisted systems), in case of single- or multiorgan 
failure or in case of death. An additional grouping accord-
ing to late complications indicated by the suffix “d” in the 
original CD classification was not considered.
All statistical analysis was performed using SPSS sta-
tistical software for Windows, version 20 (SPSS, Inc, an 
IBM Company, Chicago, Ill., USA). Pearson χ2 tests were 
used to determine the association between categorical 
variables. Binary logistic regression was used to identify 
independent predictors of increased severe complication 
rate with an inclusion threshold of P ≤ 0.05. To determine 
variables predicting length of hospitalization, a Cox-re-
gression model was used with an inclusion threshold of 
P ≤ 0.05. Cases with covariate data missing or unknown 
were excluded from the multivariate analysis. Effects of cat-
egorical variables were reported as odds ratios (ORs). In 
all cases, a P ≤ 0.05 was considered statistically significant.
RESULTS
Rates	and	Type	of	Complications
The overall rate of complications in this group of 217 pa-
tients based on the modified classification was 42%: 14.7% 
severe and 27.3% minor complications. Twelve patients 
(5.5%) were found with complete flap losses and 15 patients 
(6.9%) with fistulas requiring additional major interventions 
prolonging the length of hospitalization. Additional compli-
cations were death in 2 patients due to multiorgan failures as 
a consequence of a sepsis and hemorrhagic shock, a myocar-
dial infarct, and a superinfected hematoma (Table 3).
Univariate	Analysis	of	Factors	Associated	with	Severe	
Complications
To identify variables significantly associated with the 
occurrence of severe complications, a univariate analysis 
was performed. This analysis returned the variables type 
of flap (P < 0.0001), ASA classification (P = 0.045), fre-
quently versus less frequently performed flap (P < 0.0001), 
microscope use for the anastomosis (P = 0.039), surgeon 
(P = 0.024), high- versus low-volume surgeon (P = 0.007), 
and T-stage (P = 0.009) as significant (Table 4).
Logistic	Regression	Analysis	of	Factors	Associated	with	
Severe	Complications
To identify factors independently associated with the 
occurrence of severe complications, a binomial logistic 
regression model was created. The model returned 3 vari-
ables independently associated with the occurrence of 
severe complications. Those were frequently versus less 
frequently performed flap (OR = 3.2; confidence interval 
[CI] = 1.7–5.8; P < 0.001), high- versus low-volume surgeon 
(OR = 0.52; CI = 0.29–0.93; P = 0.007), and ASA classifica-
tion (OR = 2.85; CI = 1.1–7.5; P = 0.045) (Fig. 2) (Table 4).
Predictors	of	Length	of	Hospitalization
To identify predictors of a prolongation of hospitaliza-
tion, a Cox-regression model using a forward likelihood 
ratio strategy was employed. The 4 variables retained in 
the model found to independently correlate with the 
length of hospitalization were T-stage (P = 0.001), com-
plication status (P = 0.015), site of the reconstruction (P < 
0.001), and surgeon (P = 0.011) (Table 5).
DISCUSSION
Within this series of 217 patients, we found a total 
of 42% complications, of which 14.7% were severe and 
27.3% minor. Although these numbers may seem initially 
quite high, they actually compare favorably with currently 
Table 3. Severe Complications According to the Modified 
CD Classification System
Severe Complications (Modified CD) 32/217 (14.7%)
Complete flap losses 12 (5.5%)
Fistulas 15 (6.9%)
Death (sepsis and multiorgan failure, shock 
and multiorgan failure)
2 (0.9%)
Myocardial infarct 1 (0.5%)
Hematoma with wound infection 1 (0.5%)
Severe complications in total numbers and percentage.
Table 2. Modified Clavien-Dindo Classification for Perioperative Complications of Head and Neck Free-flap Procedures
Grade I: Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and 
radiological interventions.
Acceptable therapeutic regimens are drugs as antiemetics, antipyretics, analgetics, diuretics, and electrolytes and physiotherapy. This grade 
also includes wound infections opened at the bedside.
Grade II: Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusions are also included.
Grade III: Requiring surgical, endoscopic, or radiological intervention for hematoma evacuation without wound-healing complications, 
minor wound dehiscence, vascular complication with complete functional salvage of the flap.
Grade IV: Requiring surgical, endoscopic, or radiological intervention for fistulas, complete or partial flap loss resulting in additional procedures.
Grade V: Life-threatening complication (including central nervous system complications)* requiring IC/ICU management.
Grade V-a: Single organ dysfunction (including dialysis).
Grade V-b: Multiorgan dysfunction.
Grade VI: Death of a patient.
In bold letters, the modifications made to the original Clavien-Dindo classification system; grades I–III are considered nonsevere complica-
tion; grades IV–VI are considered severe complication.
*Brain hemorrhage, ischemic stroke, subarachnoidal bleeding, but excluding TIA, IC, and ICU.
IC indicates intermediate care; ICU, intensive care unit; TIA, transient ischemic attacks.
 Broome et al. • Incidence of Severe Complications—Factor Analysis
5
published literature on complications after free-flap pro-
cedures for the head and neck region. A previously pub-
lished study on 185 patients reconstructed with free flaps 
for head and neck defects reports 53% overall complica-
tions and 40% severe complications,16 whereas a similar 
study on 304 patients reconstructed with similar tech-
niques reports an overall complication rate of 32.5% and 
a severe complication rate of 20%.17 Although seemingly 
favorable, the rates of severe complications in this study 
need to be considered in the context of the modified CD 
classification that reports complications only as severe that 
are rather prolonging hospital stay. It is likely that if the 
original CD classification would have been used, the re-
sults would have been similar to the published literature. 
A severe complication rate of nearly 15%, which is also 
associated with a high risk of prolongation of the hospital-
ization, has to be considered seriously. It means that major 
efforts are needed to reduce this number, not only to im-
prove the quality of treatment for our patients but also to 
reduce the costs that are associated with the prolongation 
of hospitalization.
It is interesting to compare this rate of severe complica-
tions with the chemoradiation literature. However, there 
are difficulties to be considered, comparing the Radiation 
Therapy Oncology Group acute toxicity rating with the 
modified CD classification. One could assume that a grade 
IV acute toxicity in a patient treated with chemoradiation 
likely results in a prolongation of the hospitalization and 
thus could be considered a severe complication, at least 
comparable with a surgical severe complication. Consider-
ing this, the reported rate of 15% severe complications in 
this study does not compare unfavorably with the reported 
incidence of grade IV acute toxicity of 18% in the chemo-
radiation group in the RTOG 99-11 trial.27
The multivariate analysis of severe complications in 
this study returned 3 variables to be independently asso-
ciated. Although 1 variable (ASA classification) belonged 
to the group of the patient-related variables, the other 2 
variables are volume-sensitive variables: high-volume sur-
geon versus low-volume surgeon and frequently versus less 
frequently performed flap. The 2 latter parameters could 
be interpreted as volume–outcome indicators. They show 
that a surgeon who performs fewer than 20 flaps a year 
should probably either try either to increase his/her activ-
ity or to quit this activity. They also show that within the 
armamentarium of a free-flap surgeon, rarely used flaps 
should be rather avoided, because if performed seem to 
bring an additional risk of complication with them. Again, 
the surgeon can choose to either increase the frequency 
of this rare flap or abandon it and choose a flap he/she 
is more acquainted with. In summary, this type of surgery 
should not be done “occasionally” by surgeons. A steady 
volume throughout the year should be maintained.
But the analysis of these data should trigger additional 
measures with regard to training young free-flap surgeons 
and surgeon–surgeon collaboration. Young head and neck 
surgeons, who start out doing free flaps in smaller volume 
centers, should probably be supervised by experienced 
surgeons throughout their gaining of independence. This 
period of surveillance could eventually last until a solid 
activity of >20 free flaps per year for the younger surgeon 
is achieved. Adequate selection of patients “appropriate” 
to be taken to surgery by the younger colleague should 
be made by the more experienced supervisor. Other 
measures to take into consideration consist of early sur-
gical simulation/training for surgeons in microvascular 
free-flap procedures. This might include training of flap 
harvest on cadavers before the interventions and comput-
Table 4. Univariate and Multivariate Analyses of Factors 











Sex    
 Male 16 NS NS
 Female 11.5 — —
Type of flap    
 Radial forearm 8.7 0.000 NS
 Fibular 25.7 — —
 Anterolateral thigh 20.0 — —
 Scapula 0.0 — —
 Rectus abdominis 60.0 — —
 Jejunum 0.0 — —
 Gracilis 0.0 — —
 Iliac crest 57.1 — —
ASA classification    
 1, 2 11.8 0.045 2.85		
(1.1–7.5)
 3, 4 23.4 — 0.033
Frequently vs less  
frequently performed  
flap
   
 Rare 38.9 0.000 3.2		
(1.7–5.8)
 Moderately frequent 24 — 0.000
 Frequent 8.7 — —
Microscope use    
 Yes 10.9 0.039 NS
 No 21.2 — —
Surgeon    
 AA 17.5 0.024 NS
 BB 0 — —
 CC 25 — —
 DD 29.7 — —
 EE 19.0 — —
 FF 7.3 — —
High- vs low-volume  
surgeon
   
 High 7.3 0.007 0.52  
(0.29–0.93)
 Moderate 23.4 — 0.028
 Low 19.4 — —
Site    
 Oropharynx 11.9 0.627 NS
 Oral cavity 15.6 — —
 Hypopharynx/larynx 16.7 — —
 Maxilla and others 11.8 — —
 Mandible 30.0 — —
T-stage    
 1, 2 7.3 0.009 NS
 3, 4 21.1 — —
Overall stage    
 Early 7.7 0.144 NS
 Advanced 17.1 — —
Prior radiotherapy    
 Yes 12.9 0.194 NS
 No 21.1 — —
Percentage of severe complications is provided; P values are recorded only if 
significant.
NS indicates not significant.
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er-based surgical simulations making use of “virtual real-
ity” environments.
The multivariate analysis in this study on duration of 
hospitalization returned the parameters “T-stage,” “severe 
complication,” “surgeon,” and “site of reconstruction” as 
independent predictors. The influence of larger T-stage 
on duration of hospitalization can be easily explained 
by the fact that larger tumors require more demanding 
reconstructions and thus a longer hospitalization for re-
habilitation. Severe complications are logically associated 
with prolonged hospitalization. In the comparison of sites, 
mandibular reconstructions had the worst outcome. It is 
of great interest to note that 1 of the 4 variables related to 
the length of hospitalization in this study is provider re-
lated; in other words, the surgeon who performs the pro-
cedure has an impact on the length of the hospitalization 
likely through the quality of the surgery provided.
In summary, we provide evidence that besides typical 
patient-related factors such as comorbidities, volume-re-
lated parameters such as the frequency with which a flap 
is performed and the activity of a surgeon impact the out-
come of microvascular free-flap procedures.
Christian Simon, MD
Department of Otolaryngology—Head and Neck Surgery
University of Lausanne, CHUV
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